Who owns the BENDEKA (BENDAMUSTINE HCI) INJECTION trademark?

The BENDEKA (BENDAMUSTINE HCI) INJECTION trademark is owned by TEVA PHARMACEUTICALS INTERNATIONAL GMBH.

What class is the BENDEKA (BENDAMUSTINE HCI) INJECTION trademark registered in?

The BENDEKA (BENDAMUSTINE HCI) INJECTION trademark is registered in Class 044 (Medical, veterinary & beauty care services).

What is the serial number for BENDEKA (BENDAMUSTINE HCI) INJECTION?

The USPTO serial number for BENDEKA (BENDAMUSTINE HCI) INJECTION is 86826918.

What is the registration number for BENDEKA (BENDAMUSTINE HCI) INJECTION?

BENDEKA (BENDAMUSTINE HCI) INJECTION is registered under USPTO registration number 5014705.

BEN

USPTO Trademark Record

REGISTERED

BENDEKA (BENDAMUSTINE HCI) INJECTION

SN 86826918·Reg 5014705·Filed Nov 20, 2015

Owner TEVA PHARMACEUTICALS INTERNATIONAL GMBH

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

BENDEKA (BENDAMUSTINE HCI) INJECTION (Serial No. 86826918), Registration No. 5014705, is a registered US trademark filed on Nov 20, 2015 by TEVA PHARMACEUTICALS INTERNATIONAL GMBH. This trademark covers Class 044 (Medical, veterinary & beauty care services).

renewal grace 10y period: February 02, 2027104 days remaining

Mark Intelligence

BENDEKA (BENDAMUSTINE HCI) INJECTION (Reg. #5014705) is a registered US trademark that has been protecting its owner, TEVA PHARMACEUTICALS INTERNATIONAL GMBH, since 2015. The mark covers Class 044 (Medical, veterinary & beauty care services). Goods and services include Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, h.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 20, 2015

SERIAL

86826918

REG#

5014705

REGISTERED

Aug 02, 2016

Owner

Applicant

TEVA PHARMACEUTICALS INTERNATIONAL GMBH

Entity

GmbH (German)

Address

145 Brandywine Parkway, West Chester, PA, 19380

Country

Attorney

NameLori Wolfe

Law firm

Lori Wolfe TEVA PHARMACEUTICALS USA, INC.

Address

400 Interpace Parkway, Building A, Parsippany, NJ 07054, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateNov 20, 2015

Serial Number86826918

Registration No.5014705

Registration DateAug 02, 2016

Status DateFeb 17, 2023

Published for OppositionMar 08, 2016

Mark TypeDesign with words

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2015

YEARS AGO

11y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Apr 27, 2016

First use in commerce: Apr 27, 2016

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

47 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 19, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 9 RECEIVED

Aug 04, 2026

TEAS SECTION 8 & 9 RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 03, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 03, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 03, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Aug 02, 2025

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Feb 17, 2023

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Feb 17, 2023

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Feb 17, 2023

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 02, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 02, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Feb 02, 2023

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 02, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS SECTION 8 & 15 RECEIVED

Aug 02, 2022

TEAS SECTION 8 & 15 RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 07, 2022

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 07, 2022

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 07, 2022

TEAS CHANGE OF CORRESPONDENCE RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 02, 2021

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 14, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 14, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 14, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Jul 14, 2021

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 14, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 14, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jul 29, 2020

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

REGISTERED-PRINCIPAL REGISTER

Aug 02, 2016

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 28, 2016

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 27, 2016

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 25, 2016

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jun 25, 2016

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jun 01, 2016

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jun 01, 2016

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 03, 2016

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 08, 2016

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 08, 2016

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 17, 2016

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 03, 2016

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Feb 02, 2016

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 29, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Dec 27, 2015

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 27, 2015

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 27, 2015

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 27, 2015

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Dec 16, 2015

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 26, 2015

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 25, 2015

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 24, 2015

NEW APPLICATION ENTERED

BENDEKA (BENDAMUSTINE HCI) INJECTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by TEVA PHARMACEUTICALS INTERNATIONAL GMBH

Other Marks in Class 044 — Medical, veterinary & beauty care services

Other Marks by Lori Wolfe

Resources

Company